Member Exclusive NEWS ROUND-UP

Cell therapy weekly: positive results for diabetic retinopathy phase III trial

This week: phase III diabetic retinopathy trial meets 24-week primary endpoint and progress on manufacturing universal donor cell therapy.

Go to the profile of RegMedNet
Mar 22, 2018

Please sign in or register for FREE

Register to RegMedNet

RegMedNet is a free content and networking hub promoting global connection, knowledge-sharing and collaboration between all members of the regenerative medicine field.


No comments yet.